Literature DB >> 10216126

Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.

A Tamori1, S Nishiguchi, S Kubo, N Koh, Y Moriyama, S Fujimoto, T Takeda, S Shiomi, K Hirohashi, H Kinoshita, S Otani, T Kuroki.   

Abstract

Serological research suggests that hepatitis B virus (HBV) and hepatitis C virus (HCV) are associated with the development of hepatocellular carcinoma (HCC). It is unclear how genes of hepatitis viruses participate in hepatocarcinogenesis in patients infected with HCV. We investigated the expression of hepatitis virus-related RNAs in resected liver from 51 patients with HCV antibodies (Ab) and without hepatitis B surface antigen (HBsAg). mRNA transcripts of the genes HBx, HBc, HBs, nonstructural (NS) region 3 of HCV, the 5'-untranslated region (UTR) of HCV, and the 5'-UTR of hepatitis G virus (HGV) were amplified by reverse-transcription polymerase chain reaction (RT-PCR) with specific primers for each gene. The HBx transcript was detected in 19 (37%) tumors and in 8 (16%) specimens of noncancerous tissues (P =.014). The NS3 gene of HCV was detected in 35 (69%) tumors and 41 (80%) noncancerous tissues. HGV RNA was detected in 3 tumors (6%). Patients with HBx transcripts were younger than patients without HBx transcripts (P =.012). HBx transcripts were detected in 3 (33%) of 9 well-differentiated HCCs, in 8 (31%) of 26 moderately differentiated HCCs, and in 8 (50%) of 16 poorly differentiated HCCs. Codon 130 (AAG) and codon 131 (GTC) of HBx were changed to ATG and ATC, respectively, in all HCCs with HBx transcripts. In conclusion, we found that the HBx gene was expressed in many HCCs; the gene might promote hepatocarcinogenesis in patients with HCVAb and without HBsAg, but HGV is not closely related to hepatocarcinogenesis in such patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216126     DOI: 10.1002/hep.510290520

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma.

Authors:  Tiziano Allice; Francesco Cerutti; Fabrizia Pittaluga; Silvia Varetto; Silvia Gabella; Alfredo Marzano; Alessandro Franchello; Giuseppe Colucci; Valeria Ghisetti
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

2.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis.

Authors:  S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 4.  Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.

Authors:  Hoang Hai; Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 5.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases.

Authors:  Seikan Hai; Shoji Kubo; Taichi Shuto; Hiromu Tanaka; Shigekazu Takemura; Takatsugu Yamamoto; Akishige Kanazawa; Masao Ogawa; Kazuhiro Hirohashi; Kenichi Wakasa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients.

Authors:  Shin-Ichi Fujioka; Hiroyuki Shimomura; Yoshiaki Iwasaki; Kozo Fujio; Hiroshi Nakagawa; Yasuhiro Onishi; Shinjiro Takagi; Hideaki Taniguchi; Fumi Umeoka; Hirofumi Nakajima; Akio Moriya; Katsuyuki Nanba; Cheng-Yu Piao; Toshiyuki Shinji; Norio Koide; Yasush Shiratori
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

8.  Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Fugui Bai; Yoshihiko Yano; Takumi Fukumoto; Atsushi Takebe; Motofumi Tanaka; Kaori Kuramitsu; Nungki Anggorowati; Hanggoro Tri Rinonce; Dewiyani Indah Widasari; Masaya Saito; Hirotaka Hirano; Takanobu Hayakumo; Yasushi Seo; Takeshi Azuma; Yonson Ku; Yoshitake Hayashi
Journal:  Int J Hepatol       Date:  2013-12-19

Review 9.  Update on occult hepatitis B virus infection.

Authors:  Manoochehr Makvandi
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

10.  HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.

Authors:  Yueming Chen; Daojun Yu; Weiying Zhang; Chunning Qiu; Guoqian Xiang; Weijian Dai; Shenghai Wu; Xianjun Wang
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.